Pacific Edge Secures Cxbladder Triage Plus Orders From Queensland Hospital; Shares Jump 6%

MT Newswires Live

Mar 05

Pacific Edge (NZE:PEB, ASX:PEB) secured orders from Queensland's Townsville University Hospital for its Cxbladder Triage Plus test under a newly implemented nurse-led clinical pathway for hematuria assessment and non-muscle invasive bladder cancer surveillance, according to a Thursday filing with the Australian and New Zealand bourses.

The hospital will use Triage Plus, a urine-based RNA and DNA genomic test, to risk-stratify hematuria patients and reduce unnecessary invasive procedures, alongside Cxbladder Monitor to decrease cystoscopy frequency in recurrent bladder cancer surveillance, the filing added.

The company's Kiwi shares jumped past 6% in recent Thursday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2617561010"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2617561010\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2617561010?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-05 05:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2617561010","market":"fut","top_or_hot":-1,"title":"Pacific Edge Secures Cxbladder Triage Plus Orders From Queensland Hospital; Shares Jump 6%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (NZE:PEB, ASX:PEB) secured orders from Queensland's Townsville University Hospital for its Cxbladder Triage Plus test under a newly implemented nurse-led clinical pathway for hematuria assessment and non-muscle invasive bladder cancer surveillance, according to a Thursday filing with the Australian and New Zealand bourses.</p><p>The hospital will use Triage Plus, a urine-based RNA and DNA genomic test, to risk-stratify hematuria patients and reduce unnecessary invasive procedures, alongside Cxbladder Monitor to decrease cystoscopy frequency in recurrent bladder cancer surveillance, the filing added.</p><p>The company's Kiwi shares jumped past 6% in recent Thursday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pacific Edge Secures Cxbladder Triage Plus Orders From Queensland Hospital; Shares Jump 6%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPacific Edge Secures Cxbladder Triage Plus Orders From Queensland Hospital; Shares Jump 6%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-05 05:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (NZE:PEB, ASX:PEB) secured orders from Queensland's Townsville University Hospital for its Cxbladder Triage Plus test under a newly implemented nurse-led clinical pathway for hematuria assessment and non-muscle invasive bladder cancer surveillance, according to a Thursday filing with the Australian and New Zealand bourses.</p><p>The hospital will use Triage Plus, a urine-based RNA and DNA genomic test, to risk-stratify hematuria patients and reduce unnecessary invasive procedures, alongside Cxbladder Monitor to decrease cystoscopy frequency in recurrent bladder cancer surveillance, the filing added.</p><p>The company's Kiwi shares jumped past 6% in recent Thursday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK8033","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2617561010","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2617561010","pubTimestamp":1772660835,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pacific Edge  secured orders from Queensland's Townsville University Hospital for its Cxbladder Triage Plus test under a newly implemented nurse-led clinical pathway for hematuria assessment and non-muscle invasive bladder cancer surveillance, according to a Thursday filing with the Australian and New Zealand bourses.The hospital will use Triage Plus, a urine-based RNA and DNA genomic test, to risk-stratify hematuria patients and reduce unnecessary invasive procedures, alongside Cxbladder Monitor to decrease cystoscopy frequency in recurrent bladder cancer surveillance, the filing added.The company's Kiwi shares jumped past 6% in recent Thursday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK8033":"生物科技","PEB.AU":"PACIFIC EDGE LTD","BK7067":"生物科技","PEB.NZ":"Pacific Edge Limited Ordinary Shares"},"translate_title":"Pacific Edge获得昆士兰医院的Cxbladder Triage Plus订单；股价上涨6%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PEB.NZ":1.5,"PEB.AU":1},"content_text":"Pacific Edge (NZE:PEB, ASX:PEB) secured orders from Queensland's Townsville University Hospital for its Cxbladder Triage Plus test under a newly implemented nurse-led clinical pathway for hematuria assessment and non-muscle invasive bladder cancer surveillance, according to a Thursday filing with the Australian and New Zealand bourses.The hospital will use Triage Plus, a urine-based RNA and DNA genomic test, to risk-stratify hematuria patients and reduce unnecessary invasive procedures, alongside Cxbladder Monitor to decrease cystoscopy frequency in recurrent bladder cancer surveillance, the filing added.The company's Kiwi shares jumped past 6% in recent Thursday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}